The current PE ratio for Prestige Consumer Healthcare stock as of Jul 11, 2025 is 17.71. This is calculated based on the current EPS of $4.32 and the stock price of $76.5 per share. The current price-to-earnings ratio is nearly the same as the last four quarters average.
The average historical PE ratio of Prestige Consumer Healthcare for the last ten years is 18.89. The current PE ratio of 17.71 is 6% below the historical average. Over the past ten years, PBH's PE ratio was at its highest in the Jun 2016 quarter at 42.95, when the stock price was $55.4 and the EPS was $1.29. The lowest value was in the Mar 2018 quarter, when it reached 5.27 with a price of $33.72 and an EPS of $6.4.
Maximum annual increase: 50.12% in 2017
Maximum annual decrease: -87.57% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2025 | 19.9 | 15.43% | $85.97 | $4.32 |
2024 | 17.24 | N/A | $72.56 | $4.21 |
2023 | N/A | N/A | $62.63 | -$1.65 |
2022 | 12.94 | -3.72% | $52.94 | $4.09 |
2021 | 13.44 | 2.99% | $44.08 | $3.28 |
2020 | 13.05 | N/A | $36.68 | $2.81 |
2019 | N/A | N/A | $29.91 | -$0.69 |
2018 | 5.27 | -87.57% | $33.72 | $6.4 |
2017 | 42.41 | 50.12% | $55.56 | $1.31 |
2016 | 28.25 | -1.19% | $53.39 | $1.89 |
2015 | 28.59 | 47.9% | $42.89 | $1.5 |
2014 | 19.33 | -2.91% | $27.25 | $1.41 |
2013 | 19.91 | -15.71% | $25.69 | $1.29 |
2012 | 23.62 | 19.11% | $17.48 | $0.74 |
2011 | 19.83 | 41.04% | $11.5 | $0.58 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 19.9 | 9.82% | $85.97 | $4.32 |
Dec 2024 | 18.12 | 4.32% | $78.09 | $4.31 |
Sep 2024 | 17.37 | 4.2% | $72.1 | $4.15 |
Jun 2024 | 16.67 | -3.31% | $68.85 | $4.13 |
Mar 2024 | 17.24 | N/A | $72.56 | $4.21 |
Dec 2023 | N/A | N/A | $61.22 | -$1.6 |
Sep 2023 | N/A | N/A | $57.19 | -$1.62 |
Jun 2023 | N/A | N/A | $59.43 | -$1.68 |
Mar 2023 | N/A | N/A | $62.63 | -$1.65 |
Dec 2022 | 14.87 | 24.12% | $62.6 | $4.21 |
Sep 2022 | 11.98 | -17.66% | $49.83 | $4.16 |
Jun 2022 | 14.55 | 12.44% | $58.8 | $4.04 |
Mar 2022 | 12.94 | -19.78% | $52.94 | $4.09 |
Dec 2021 | 16.13 | 2.61% | $60.65 | $3.76 |
Sep 2021 | 15.72 | 7.45% | $56.11 | $3.57 |
PBH's current P/E ratio is above the 3 and 5-year historical averages, but it is below the 10-year average.
PBH's PE ratio is lower than its peer stocks PG and NVS, but it is greater than JNJ's and ABT's. Prestige Consumer Healthcare's current PE ratio of 17.71 is below the average of its peers, which is 19.14.
Stock name | PE ratio | Market cap |
---|---|---|
CVS CVS HEALTH Corp | 15.42 | $81.95B |
ABT Abbott Laboratories | 17.1 | $229.69B |
JNJ Johnson & Johnson | 17.32 | $377.51B |
PBH Prestige Consumer Healthcare Inc | 17.71 | $3.78B |
PFE Pfizer Inc | 18.45 | $145.83B |
NVS Novartis AG | 18.79 | $237.11B |
CLX Clorox Co | 22.6 | $15.6B |
PG PROCTER & GAMBLE Co | 24.31 | $368.21B |
The price to earnings ratio for PBH stock is 17.71 as of Jul 11, 2025.
The average PE ratio for PBH stock over the past 3 years is 16.59.
The average PE ratio for PBH stock over the past 5 years is 15.02.
In the last ten years, the Jun 2016 quarter recorded the highest quarterly PE ratio at 42.95.
The current price to earnings ratio of PBH is 6% lower than the 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jul 11, 2025), Prestige Consumer Healthcare's stock price is $76.5. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $4.32. Therefore, Prestige Consumer Healthcare's P/E ratio for today is 17.71. PE RATIO(17.71) = STOCK PRICE($76.5) / TTM EPS($4.32)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.